Clopidogrel Taw Pharma (previously Clopidogrel Mylan) Uniunea Europeană - română - EMA (European Medicines Agency)

clopidogrel taw pharma (previously clopidogrel mylan)

taw pharma (ireland) limited - clopidogrel clorhidrat - peripheral vascular diseases; stroke; myocardial infarction; acute coronary syndrome - agenți antitrombotici - , , , , secondary prevention of atherothrombotic events, , clopidogrel is indicated in: , - adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. , - adult patients suffering from acute coronary syndrome:,    - non-st segment elevation acute coronary syndrome (unstable angina or non-q-wave myocardial infarction), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). ,     - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapy. , , in patients with moderate to high-risk transient ischaemic attack (tia) or minor ischaemic stroke (is), clopidogrel in combination with asa is indicated in:, - adult patients with moderate to high-risk tia (abcd2  score ≥4) or minor is (nihss  ≤3) within 24 hours of either the tia or is event.  , , prevention of atherothrombotic and thromboembolic events in atrial fibrillation, in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for treatment with vitamin k antagonists (vka) and who have a low bleeding risk, clopidogrel is indicated in combination with asa for the prevention of atherothrombotic and thromboembolic events, including stroke. , , for further information please refer to section 5. , , ,.

LEVETIRACETAM POLIPHARMA 100 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

levetiracetam polipharma 100 mg/ml

polipharma industries s.r.l. - levetiracetamum - sol. orala - 100mg/ml - antiepileptice alte antiepileptice

CABAZITAXEL EVER PHARMA 10 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

cabazitaxel ever pharma 10 mg/ml

ever pharma jena gmbh - germania - cabazitaxelum - conc. pt. sol. perf. - 10mg/ml - alcaloizi din plante si alte produse naturale taxani

Skytrofa (previously Lonapegsomatropin Ascendis Pharma) Uniunea Europeană - română - EMA (European Medicines Agency)

skytrofa (previously lonapegsomatropin ascendis pharma)

ascendis pharma endocrinology division a/s - lonapegsomatropin - growth and development - hormoni hipofizari și hipotalamici și analogi - growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion (growth hormone deficiency [ghd]),.

ACETAT DE TERLIPRESINA EVER PHARMA 0,2 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

acetat de terlipresina ever pharma 0,2 mg/ml

ever pharma jena gmbh - germania - terlipressinum - sol. inj. - 0,2mg/ml - hormoni ai lobului posterior hipofizar hormon antidiuretic (adh) si analogi

FULVESTRANT EVER PHARMA 250 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fulvestrant ever pharma 250 mg

ever pharma jena gmbh - germania - fulvestrantum - sol. inj. in seringa preumpluta - 250mg - antagonisti hormonali si substante inrudite antiestrogeni

PEMETREXED EVER PHARMA 25 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

pemetrexed ever pharma 25 mg/ml

ever pharma jena gmbh - germania - pemetrexedum - conc. pt. sol. perf. - 25mg/ml - antimetaboliti analogi ai acidului folic

CUTAQUIG 165 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

cutaquig 165 mg/ml

octapharma pharmazeutika produktionsges m.b.h. - austria - imunoglobulina umana normala - sol. inj. subcutana - 165mg/ml - imunoglobuline imunoglobulina umana de origine umana

FIBRYGA 1 g România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

fibryga 1 g

octapharma pharmazeutika produktionsges m.b.h. - austria - fibrinogen uman - pulb.+solv. pt. sol. inj./perf. - 1g - vitamina k si alte hemostatice fibrinogen

GAMMANORM 165 mg/ml România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gammanorm 165 mg/ml

octapharma ab - suedia - imunoglobulina umana normala - sol. inj. subcutana - 165mg/ml - imunoglobuline imunoglobulina umana de origine umana